...
首页> 外文期刊>Journal of Clinical Microbiology >Serological Determination of Hepatitis C Virus Subtypes 1a, 1b, 2a, 2b, 3a, and 4a by a Recombinant Immunoblot Assay
【24h】

Serological Determination of Hepatitis C Virus Subtypes 1a, 1b, 2a, 2b, 3a, and 4a by a Recombinant Immunoblot Assay

机译:重组免疫印迹法血清学测定丙型肝炎病毒亚型1a,1b,2a,2b,3a和4a

获取原文
           

摘要

Serological determination of hepatitis C virus (HCV) subtypes has been hampered by the lack of suitable assays. Therefore, a recombinant immunoblot assay has been established for serological differentiation of HCV subtypes 1a, 1b, 2a, 2b, 3a, and 4a. It consists of recombinant HCV proteins from the NS-4 region propagated in Escherichia coli. To confirm the serotyping assay results, the results were compared with those obtained by nucleotide sequencing of the NS-5 region. Sera from 157 patients with chronic HCV infection were examined by this assay, and specific antibodies could be detected in 86% (n = 135) of them. The HCV genotype was determined correctly in all but one sample, and the subtypes determined by the serotyping assay corresponded to the HCV subtypes detected by nucleotide sequencing for 95% (n = 128) of the samples. These data indicate that HCV subtypes can be distinguished serologically. The assay that is described provides an easier means of identification of infection with different HCV subtypes for wider clinical and epidemiological applications.
机译:缺乏合适的检测方法阻碍了丙型肝炎病毒(HCV)亚型的血清学测定。因此,已经建立了用于HCV亚型1a,1b,2a,2b,3a和4a的血清学分化的重组免疫印迹测定法。它由在大肠杆菌中繁殖的NS-4区的重组HCV蛋白组成。为了确认血清分型测定结果,将结果与通过NS-5区域的核苷酸测序获得的结果进行比较。通过此测定法检查了157例慢性HCV感染患者的血清,其中86%( n = 135)的特异性抗体可被检测到。除了一个样本外,其他所有样本均正确确定了HCV基因型,通过血清分型分析确定的亚型与通过核苷酸测序检测到的95%( n = 128)样本中的HCV亚型相对应。这些数据表明HCV亚型可以在血清学上区分。所描述的测定法为更广泛的临床和流行病学应用提供了一种更容易的方法,用于鉴定具有不同HCV亚型的感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号